This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.
| Item | Details |
|---|---|
| A. Classification codes | ICD-10: Q04.6 | Special Copayment Reduction: V240 |
| B. Synonyms | — |
| C. Adult onset | Very low — a congenital cerebral cleft malformation that, in principle, is diagnosed in the prenatal, neonatal, or infant period; mild open-lip schizencephaly may rarely go without symptoms until adulthood and be discovered then. |
| 1. History | 1946 first named by Yakovlev and Wadsworth → 1989 MRI-based classification by Barkovich and Kjos → recently, genetic causes such as EMX2 and SHH elucidated. |
| 2. Causes | Gene variants (EMX2, SHH, SIX3, COL4A1), intrauterine ischemia, infection (CMV), trauma; mostly sporadic occurrence. |
| 3. Genetics | EMX2 (10q26) autosomal dominant; COL4A1 (13q34); some familial recurrences reported; the majority are new mutations or non-hereditary. |
| 4. General epidemiology | 1.54 per 100,000 births; unilateral about 65%, bilateral about 35%; equal in males and females. |
| 5. Pathophysiology | Destruction of the neuroepithelium at weeks 5–6 of cerebral cortex development → formation of a cleft at the pia-ependymal junction → cleft penetrating from the ventricle to the pia. |
| 6. Symptoms | Seizures (most common), hemiplegia (unilateral open-lip), quadriplegia (bilateral open-lip), developmental delay, microcephaly; closed-lip (fused-lip) type may be mild. |
| 7. Signs | Hemiplegia or quadriplegia, spasticity, cranial nerve abnormalities, visual abnormalities; on MRI, a cleft penetrating from the ventricle to the pia. |
| 8. Screening | Prenatal ultrasound (after 20 weeks); fetal MRI (supplementary if abnormal); prenatal genetic testing in high-risk groups. |
| 9. Diagnosis | Brain MRI (classification as closed-lip/open-lip, cleft location and extent); gene panel; CMV serology. |
| 10. Treatment | No cure; anticonvulsants; physical, occupational, and speech rehabilitation; shunt surgery if hydrocephalus is present; use of assistive devices. |
| 11. Prognosis | Closed-lip unilateral: relatively favorable; open-lip bilateral: severe neurodevelopmental disorder; seizure control is the key prognostic factor. |
| 12. Prevention | CMV prevention during pregnancy, avoidance of alcohol and teratogenic drugs, genetic counseling, prenatal detailed ultrasound. |
| 13. References | Barkovich AJ et al. 1992 and 9 other references |
Schizencephaly is a malformation of cortical development characterized by a congenital cleft penetrating the cerebral hemisphere. The first systematic description of this disease was made in 1946 by the American neuroanatomists Paul Ivan Yakovlev and Robert C. Wadsworth. They described in detail the pathologic anatomical findings of brains with a penetrating cleft extending from the ventricular lining (ependyma) to the pia mater on the brain surface, and named this unique malformation 'schizencephaly.' Yakovlev and Wadsworth also emphasized that the walls of the cleft are lined with gray matter, making clear that it is a developmental malformation distinct from a simple brain cyst or a defect after cerebral infarction.
The introduction of CT in the 1970s and 1980s made it possible to diagnose schizencephaly during life. In 1989, A. James Barkovich and Barry Kjos published the first large-scale MRI imaging study of schizencephaly, classifying it into two subtypes: closed-lip (type I), in which the walls of the cleft are in contact with each other, and open-lip (type II), in which the walls are separated. This classification is still used as the clinical standard today. This study also clearly confirmed that schizencephaly is frequently accompanied by other malformations of cortical development (gyral dysplasia, heterotopia, etc.).
With advances in molecular genetics, EMX2 (empty spiracles homolog 2) gene variants were identified in some cases of schizencephaly (Brunelli et al., 1996), and variants in genes such as SHH (Sonic hedgehog), SIX3, and COL4A1 were subsequently also reported to be associated with some cases. However, a clear genetic cause has still not been identified in the majority of schizencephaly patients, so the interaction of environmental factors such as intrauterine ischemia and CMV infection with genetic predisposition is emphasized as important in its occurrence. In Korea, diagnosed cases have been increasing since the 2010s with the spread of brain MRI and genetic testing, and medical expense support is available through V240 registration of Special Copayment Reduction.
The causes of schizencephaly are broadly divided into genetic factors, intrauterine environmental factors, and the combined interaction of the two. In the majority of patients, the combined action of multiple factors is understood to be involved rather than a single clear cause.
Genetic causes: The EMX2 (10q26.11) gene encodes a homeobox transcription factor involved in the proliferation and differentiation of neuroepithelial cells in early brain development. EMX2 loss-of-function variants have been identified in some familial and sporadic cases of schizencephaly. Variants in components of the SHH (Sonic Hedgehog) signaling pathway (SHH, SIX3) are also associated with some cases. COL4A1 (13q34) gene variants can cause schizencephaly by inducing focal ischemia during brain development through abnormalities of vessel wall structure. However, schizencephaly explained by gene variants accounts for a minority of all patients, and in the majority the genetic cause is unclear.
Intrauterine environmental factors: Cytomegalovirus (CMV) infection during pregnancy shows a strong association with schizencephaly. CMV directly infects neuroepithelial cells and induces cell death, which can lead to destruction of the neuroepithelium and cleft formation during the period of cerebral cortical development. Intrauterine focal ischemia (vascular occlusion, placental insufficiency, twin-to-twin transfusion syndrome, etc.), trauma (direct intrauterine injury), and exposure to toxins (cocaine, alcohol) are also reported as environmental risk factors for schizencephaly.
Idiopathic: A substantial proportion of cases remain unexplained even after genetic testing and investigation of environmental factors, and gene-environment interactions not yet identified are presumed to be involved.
The genetic basis of schizencephaly has not been established as a single-gene disease, and various genes are associated with a small number of cases. Most schizencephaly occurs sporadically, and familial recurrence is rare.
EMX2 (10q26.11): A homeobox transcription factor gene essential for proliferation of periventricular neuroepithelial cells at weeks 5–7 of brain development. EMX2 haploinsufficiency or loss-of-function mutations have been associated with some sporadic and familial schizencephaly. The penetrance of heterozygous variants tends to be low, and phenotypic heterogeneity is large even within the same family.
COL4A1 (13q34): The collagen type IV alpha 1 chain gene, essential for basement membrane structure. COL4A1 variants cause small vessel fragility, resulting in focal hemorrhage and ischemia during brain development, and can cause schizencephaly or schizencephaly-like lesions. Inherited in an autosomal dominant manner and associated with a multi-organ phenotype including stroke, renal failure, and muscle cramps.
SHH pathway genes: SHH, SIX3, and CDON variants are rarely reported in schizencephaly along with the holoprosencephaly spectrum. This pathway is important for forebrain midline structures and cortical development.
In cases with reported familial recurrence, the mode of inheritance is presumed to be autosomal dominant, but occurrence due to germline mosaicism should also be considered. Clinical and imaging evaluation of the parents and molecular genetic testing are important for assessing recurrence risk. When schizencephaly is diagnosed, chromosomal microarray (CMA), an NGS-based panel of cortical malformation genes, and, if needed, WES/WGS are recommended.
Schizencephaly is a relatively rare congenital brain malformation, reported at a frequency of 1 in about 65,000–100,000 births (about 1.54 per 100,000 births). Unilateral schizencephaly accounts for about 65%, and bilateral about 35%. Among unilateral cases, clefts in the left hemisphere are reported to be slightly more common than in the right. A difference in frequency by sex is generally not reported.
Which of closed-lip (type I) and open-lip (type II) is more common varies by study, but in MRI-based studies open-lip is reported as somewhat more common. Schizencephaly is identified in about 0.5–2% of all pediatric epilepsy patients, and there is also a report that schizencephaly is found on brain MRI in about 15–25% of pediatric patients presenting with hemiplegia.
The frequency of associated malformations is high, and in about 60–70% of all patients other malformations of cortical development such as heterotopia, polymicrogyria, corpus callosum abnormalities, and hemispheric hypoplasia accompany it. Hydrocephalus also accompanies it in about 20–30%. In Korea, schizencephaly is regarded as a relatively rare diagnosis in rare disease registration and pediatric neurology clinical data, but diagnosed cases are gradually increasing with the spread of MRI.
The core pathophysiology of schizencephaly is that focal destruction of the neuroepithelium occurs in early cerebral cortical development (weeks 5–6 of gestation), forming a penetrating cleft from the ventricular lining to the pia on the brain surface. The walls of this cleft are lined with gray matter (dysplastic cortex), which distinguishes it from a simple post-traumatic brain defect or cyst.
Mechanism of neuroepithelial destruction: During the period of rapid neuroepithelial proliferation at weeks 5–6 of brain development, if focal ischemia (vascular occlusion, maternal hypotension, twin-to-twin transfusion syndrome), direct destruction of the neuroepithelium by CMV infection, or genetic loss of neuroepithelial cells occurs, a cleft extending from the ventricle to the pia forms at that site. Initially the walls of the cleft are in contact, forming closed-lip schizencephaly, and if the lesion is larger or the damage continues, the walls separate and it becomes open-lip.
Cortical dysplasia and cleft walls: The cleft walls are composed of dysplastic cortex rather than normal cortical architecture, and polymicrogyria tissue commonly accompanies the periphery of the cleft. This suggests that the cortical development abnormality progresses both before and after cleft formation. The accompanying gyral dysplasia contributes additionally to seizures and neurodevelopmental disorder.
Mechanism of hydrocephalus: In open-lip schizencephaly, movement of cerebrospinal fluid through the cleft, accompanying ventricular dilatation, and corpus callosum abnormalities can cause hydrocephalus. Hydrocephalus is less common in the closed-lip type.
The clinical symptoms of schizencephaly vary widely depending on the location of the cleft, the subtype (closed-lip/open-lip), unilateral/bilateral involvement, and the presence of associated malformations.
Seizures: The most common symptom, occurring in about 60–80% of all patients. Focal seizures are the most common, and secondary generalization may occur. Seizures often begin in infancy or early childhood, and drug-refractory seizures are also frequent. There are also reports that seizures are more common in the closed-lip type than in the open-lip type.
Motor disorders: In unilateral schizencephaly, contralateral hemiplegia or hemiparesis is characteristic. Paralysis is more severe when the lesion is located in or near the motor cortex. In bilateral schizencephaly, tetraplegia and spastic quadriplegia resembling cerebral palsy may occur. Increased muscle tone (spasticity) and hyperreflexia of deep tendon reflexes accompany it.
Developmental delay and intellectual disability: Motor, language, and cognitive development are delayed to varying degrees. Unilateral closed-lip cases show relatively mild developmental delay, whereas in bilateral open-lip cases severe intellectual disability and communication disorder are common.
Other symptoms: Visual abnormalities (decreased vision due to optic nerve hypoplasia, strabismus), abnormal head growth (microcephaly, rarely macrocephaly), and symptoms of raised intracranial pressure due to hydrocephalus may accompany it.
Characteristic findings of schizencephaly are identified on physical examination and neuroimaging.
Neurologic signs: In unilateral schizencephaly, contralateral hemiplegia (upper limb predominance is common), spasticity, hyperreflexia of deep tendon reflexes, and a positive Babinski reflex are observed. In bilateral cases, limb spasticity, pseudobulbar palsy (dysarthria, dysphagia), and uncontrolled emotional expression appear. Eye movement abnormalities (strabismus, nystagmus) are observed together with optic nerve hypoplasia or frontal lobe lesions.
Brain MRI signs: Closed-lip (type I): a cleft extending from the ventricle to the pia is present with the walls in contact, and the inner walls of the cleft are lined with gray matter (dysplastic cortex). On T2-weighted images, the gray matter of the cleft wall and adjacent polymicrogyria are identified. Open-lip (type II): the cleft walls are separated and open, and cerebrospinal fluid fills the cleft. Extensive cortical dysplasia often accompanies the periphery of the cleft. The location and size of the cleft, whether unilateral or bilateral, and the presence of accompanying polymicrogyria and heterotopia are important for prognostic assessment.
Electroencephalography (EEG) findings: Focal epileptiform discharges are observed at the cleft site and in adjacent areas of cortical dysplasia. In some cases generalized abnormal findings (slow background activity, multifocal epileptiform discharges) appear. Video-EEG monitoring is important for characterizing seizure types and for preoperative evaluation.
Universal screening of the general population for schizencephaly is not performed. Prenatal ultrasound effectively serves as the screening tool, and if abnormal findings are present, they are confirmed with fetal MRI.
Prenatal ultrasound: Schizencephaly can be suspected when brain abnormalities (ventricular asymmetry, abnormal brain midline, abnormal brain parenchymal findings) are found on detailed ultrasound at 18–22 weeks of gestation. However, in the closed-lip type the ventricles are normal or only mildly dilated on ultrasound, so it is difficult to diagnose with prenatal ultrasound alone. In the open-lip type, ventricular dilatation or asymmetry is prominent, making suspicion possible.
Fetal MRI: Fetal MRI is performed when a brain abnormality is suspected on prenatal ultrasound. Fetal MRI after 28 weeks of gestation allows more precise evaluation of the cleft location, subtype, and accompanying cortical dysplasia. Fetal MRI provides important information for prenatal prognostic counseling and delivery planning.
Prenatal genetic testing: When there is a family history or schizencephaly occurred in a previous pregnancy, prenatal genetic testing (analysis of related genes such as EMX2 and COL4A1 in fetal DNA) is considered together with genetic counseling. It is also important to perform CMV serology early in pregnant women to check for infection.
The diagnosis of schizencephaly is confirmed based on characteristic brain MRI findings, and genetic testing and CMV testing are performed in parallel to identify the cause.
Brain MRI: The diagnostic standard; high-resolution MRI including T1-, T2-, and FLAIR-weighted images is performed. Diagnostic criteria: (1) a penetrating cleft extending from the ventricular lining (ependyma) to the pia mater, (2) the inner walls of the cleft lined with gray matter (dysplastic cortex, polymicrogyria). Closed-lip (type I): cleft walls in contact; open-lip (type II): cleft walls separated, filled with cerebrospinal fluid. The cleft location (motor, language, visual cortex), unilateral/bilateral involvement, size, and accompanying malformations (polymicrogyria, heterotopia, corpus callosum abnormalities, optic nerve hypoplasia, septo-optic dysplasia) are systematically evaluated.
CMV serology and molecular testing: When schizencephaly is confirmed in a newborn, urine, blood, and cerebrospinal fluid CMV PCR tests are performed to check for congenital CMV infection. If congenital CMV infection is confirmed, evaluation of the indication for antiviral treatment (valganciclovir) and long-term hearing follow-up are needed.
Genetic testing: Chromosomal microarray (CMA) and an NGS-based gene panel for malformations of cortical development (including EMX2, COL4A1, SHH, SIX3, etc.) are performed. If there is a family history, testing of the parents is performed in parallel. If the panel is negative, WES/WGS is considered.
There is currently no treatment for the underlying cause of schizencephaly, and seizure control, motor function rehabilitation, and developmental support are the core of treatment.
Seizure treatment: An appropriate anticonvulsant is selected according to seizure type. Levetiracetam, oxcarbazepine, lamotrigine, and others are used for focal seizures. For drug-refractory seizures, the ketogenic diet, vagus nerve stimulation (VNS), and epilepsy surgery (cortical resection at the cleft site or hemispherotomy) are considered. In epilepsy surgery, it is important to evaluate whether the cleft site and accompanying cortical dysplasia correspond to the epileptogenic zone.
Rehabilitation treatment: Physical therapy for hemiplegia or quadriplegia (strengthening, maintaining joint range of motion, use of assistive devices), occupational therapy (hand function, training in activities of daily living), and speech therapy (dysarthria, dysphagia, augmentative and alternative communication) are the core. Starting rehabilitation as early as possible through early intervention programs improves functional prognosis.
Hydrocephalus treatment: If hydrocephalus is present, a VP shunt or ETV is performed. If there is optic nerve hypoplasia, ophthalmologic follow-up and low-vision aids are needed.
Special education and support: Special education, learning support, and emotional support are needed for intellectual disability and developmental delay. Palliative care support and linkage to social services for caregivers of patients with severe disability are also important.
The prognosis of schizencephaly varies widely depending on the cleft subtype, unilateral/bilateral involvement, location, and accompanying malformations.
Closed-lip unilateral: Shows a relatively favorable prognosis, with mild hemiplegia and controllable seizures as the main problems. Some patients retain normal intelligence and can live independently. Age at seizure onset, seizure frequency, and the extent of accompanying cortical dysplasia are important for predicting individual prognosis.
Open-lip unilateral: Hemiplegia is more severe and seizure control is often difficult. Delays in motor and cognitive development are common, and continuous rehabilitation and educational support are needed.
Bilateral (closed-lip or open-lip): Quadriplegia, severe intellectual disability, treatment-resistant seizures, and pseudobulbar palsy are characteristic. Development of independent mobility, language, and communication is very limited. Management of secondary complications such as aspiration pneumonia and malnutrition is important, and a palliative care approach is often needed.
Seizure control and prognosis: Whether seizures are drug-responsive is assessed as the single most important factor for functional prognosis. Cases have been reported in which cognitive and behavioral function improved significantly in patients with good epilepsy surgery outcomes.
Complete prevention of schizencephaly is not possible, but management of major risk factors and genetic counseling contribute to prevention.
Prevention of CMV infection: Preventing cytomegalovirus infection during pregnancy is important. Hand hygiene (washing after contact with infant and toddler diapers and secretions), use of CMV-negative blood products, and CMV serology monitoring of pregnant women help. For CMV-negative pregnant women, caution about contact with a CMV-positive partner and hygiene education in childcare settings are recommended.
Management of intrauterine ischemia risk factors: In twin pregnancies, early detection of twin-to-twin transfusion syndrome (TTTS), prevention of maternal hypotension, and monitoring of placental function may contribute to preventing brain malformations caused by intrauterine ischemia.
Genetic counseling and prenatal diagnosis: If schizencephaly occurred in a previous pregnancy or a genetic variant has been identified, genetic counseling, prenatal genetic testing (analysis of fetal DNA), and preimplantation genetic testing (PGT) are considered. Early diagnosis through detailed ultrasound and fetal MRI during pregnancy allows preparation for delivery planning and neonatal intensive care.